| Nurix Therapeutics, Inc. | 25,000 | US$607K | 0.32% |
| Incyte Corporation | 5,300 | US$601K | 0.32% |
| Argenx Se | 641 | US$595K | 0.32% |
| Disc Medicine, Inc. | 8,000 | US$585K | 0.31% |
| Rapport Therapeutics, Inc. | 14,000 | US$583K | 0.31% |
| Ultragenyx Pharmaceutical Inc. | 17,000 | US$568K | 0.30% |
| Trevi Therapeutics, Inc. | 30,000 | US$560K | 0.30% |
| Monte Rosa Therapeutics, Inc. | 23,000 | US$557K | 0.30% |
| Tg Therapeutics, Inc. | 10,000 | US$549K | 0.29% |
| Halozyme Therapeutics, Inc. | 7,000 | US$548K | 0.29% |
| Ionis Pharmaceuticals, Inc. | 6,800 | US$539K | 0.29% |
| Arcutis Biotherapeutics, Inc. | 19,700 | US$517K | 0.27% |
| Aurinia Pharmaceuticals Inc | 30,000 | US$509K | 0.27% |
| Neurocrine Biosciences, Inc. | 3,000 | US$506K | 0.27% |
| Immunovant, Inc. | 13,000 | US$501K | 0.27% |
| Acadia Pharmaceuticals Inc. | 19,766 | US$500K | 0.27% |
| Ptc Therapeutics, Inc. | 6,000 | US$489K | 0.26% |
| Celldex Therapeutics, Inc. | 13,000 | US$484K | 0.26% |
| Definium Therapeutics, Inc. | 10,000 | US$470K | 0.25% |
| Cogent Biosciences, Inc. | 12,000 | US$464K | 0.25% |
| Kymera Therapeutics, Inc. | 4,000 | US$459K | 0.24% |
| Dyne Therapeutics, Inc. | 20,000 | US$444K | 0.24% |
| Alnylam Pharmaceuticals, Inc. | 1,465 | US$441K | 0.23% |
| Tarsus Pharmaceuticals, Inc. | 7,000 | US$441K | 0.23% |
| Syndax Pharmaceuticals, Inc. | 20,000 | US$437K | 0.23% |
| Exelixis, Inc. | 8,000 | US$435K | 0.23% |
| Crinetics Pharmaceuticals, Inc. | 11,000 | US$412K | 0.22% |
| Liquidia Corporation | 5,000 | US$399K | 0.21% |
| Stoke Therapeutics, Inc. | 12,000 | US$393K | 0.21% |
| Viking Therapeutics, Inc. | 10,000 | US$390K | 0.21% |
| Immunome, Inc. | 18,000 | US$381K | 0.20% |
| Protagonist Therapeutics, Inc. | 3,000 | US$368K | 0.20% |
| Harmony Biosciences Holdings, Inc. | 10,000 | US$364K | 0.19% |
| Enliven Therapeutics, Inc. | 7,000 | US$355K | 0.19% |
| Spyre Therapeutics, Inc. | 4,000 | US$355K | 0.19% |
| Intellia Therapeutics, Inc. | 20,000 | US$338K | 0.18% |
| Madrigal Pharmaceuticals, Inc. | 600 | US$322K | 0.17% |
| Tango Therapeutics, Inc. | 10,000 | US$313K | 0.17% |
| Ardelyx, Inc. | 60,000 | US$306K | 0.16% |
| Vera Therapeutics, Inc. | 7,000 | US$300K | 0.16% |
| Mirum Pharmaceuticals, Inc. | 2,500 | US$293K | 0.16% |
| Oruka Therapeutics, Inc. | 3,000 | US$286K | 0.15% |
| Supernus Pharmaceuticals, Inc. | 6,000 | US$279K | 0.15% |
| Zymeworks Inc. | 10,000 | US$261K | 0.14% |
| Krystal Biotech, Inc. | 692 | US$257K | 0.14% |
| Xenon Pharmaceuticals Inc. | 4,200 | US$254K | 0.13% |
| Axsome Therapeutics, Inc. | 1,000 | US$245K | 0.13% |
| Arrivent Biopharma, Inc. | 7,041 | US$245K | 0.13% |
| Dianthus Therapeutics, Inc. | 2,500 | US$244K | 0.13% |
| Kodiak Sciences Inc | 6,000 | US$234K | 0.12% |
| Revolution Medicines, Inc. | 1,200 | US$225K | 0.12% |
| Bridgebio Pharma, Inc. | 3,000 | US$223K | 0.12% |
| Rhythm Pharmaceuticals, Inc. | 2,000 | US$222K | 0.12% |
| Denali Therapeutics Inc. | 8,463 | US$218K | 0.12% |
| Arrowhead Pharmaceuticals, Inc. | 2,600 | US$212K | 0.11% |
| Scholar Rock Holding Corporation | 3,827 | US$210K | 0.11% |
| Edgewise Therapeutics, Inc. | 5,000 | US$203K | 0.11% |
| Amylyx Pharmaceuticals, Inc. | 10,838 | US$195K | 0.10% |
| Cytomx Therapeutics, Inc. | 39,400 | US$148K | 0.08% |
| Ocular Therapeutix, Inc. | 15,000 | US$147K | 0.08% |
| Eyepoint, Inc. | 10,000 | US$143K | 0.08% |
| Oric Pharmaceuticals, Inc. | 13,000 | US$141K | 0.07% |
| Olema Pharmaceuticals, Inc. | 10,000 | US$125K | 0.07% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Celcuity Inc. | 0 | US$0 | 0.00% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Erasca, Inc. | 0 | US$0 | 0.00% |
| Inhibrx Biosciences, Inc. | 0 | US$0 | 0.00% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Praxis Precision Medicines, Inc. | 0 | US$0 | 0.00% |
| Sera Prognostics, Inc. | 0 | US$0 | 0.00% |
| Summit Therapeutics Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| United Therapeutics Corporation | 0 | US$0 | 0.00% |
| Cytokinetics, Incorporated | 0 | US$0 | 0.00% |
| Agios Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |